Walleye Capital LLC Annexon, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $616,594 - $1.75 Million	378,279 New	378,279 $1.72 Million
Q2 2022 Aug 08, 2022	SELL	$2.11 - $4.06 $517,485 - $995,731	-245,254 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.73 - $11.94 $526,144 - $2.3 Million	192,727 Added 366.91%	245,254 $670,000
Q4 2021 Mar 03, 2022	BUY	$11.49 - $22.0 $603,535 - $1.16 Million	52,527 New	52,527 $603,000

157

101M

3.61M

1.08M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $344M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.